The discussion on psychiatric diagnoses and descriptive labels continues…

What day celebrates all human beings?

New data shared at ECNP Congress informs clinicians of how best to switch patients from a once-monthly subcutaneous injection of Perseris to risperidone (Uzedy).

There is still no formal or professional recognition of complex PTSD as a very different disorder than what DSM-5-TR describes for PTSD.

Is forcing a school shooter to donate his brain to scientific study unethical?

"...I swear to not be in a half-assed rush, wear helmet & ear guards, keep my gloves on for even a fast cut..."

Our chosen image of what and who we are in this world.

Explore the most recent data on adult ADHD with the president of the American Professional Society for ADHD and Related Disorders.

The CDC just released new data that highlight issues around adult ADHD prevalence, diagnosis, and treatment.

What is genuine resilience, and what pressures impede the provision of support needed to foster it?

One reader responds to the suggestion that presidential candidates undergo independent medical evaluations.

Today is World Mental Health Day. Here's a note from our CEO.

Work, burnout, war, and disastrous weather: issues in our collective mental health.

The FDA has granted Fast Track designation to liafensine for the treatment of patients with treatment-resistant depression.

How do elite athletes lean on their faith and mental health caregivers during times of adversity?

As a treatment, low-dose lithium can act like a bridge between medications and integrative approaches, supporting well-being with reduced adverse effects.

Is it time to take patient healing further?

Learn more about how cognitive behavior therapy can be used as a healing tool in marginalized communities.

Nothing prevents psychiatrists from taking full part in the political process or even the culture wars—as long as they do it outside of their roles as psychiatrists, says one doctor.

“If I am not for myself, who will be? If I am only for myself, what am I? If not now, when?”

Novel treatment for cocaine use disorder? Researchers performed a randomized, double-blind, placebo-controlled trial of lorcaserin.

Do you want to be featured in our online series and potentially in print for an upcoming Special Report? Check out our October theme!

Clinicians can ensure high-quality care by remaining informed about legal and ethical considerations in navigating patient privacy dilemmas.

Any efforts to build lasting peace cannot ignore the massive mental health needs in war-torn regions.

Jelena Kunovac, MD, MS, discusses last week's approval of Cobenfy, an agent with a novel mechanism of action that could revolutionize schizophrenia treatment.